natgillin/translations-raw huggingface dataset:
Surprisingly, the two compounds given in doses which alone were not effective at all, led, when administered simultaneously, to a very strong bronchodilatory effect in guinea pigs clearly indicating the overadditive nature of this interaction. 
Iznenađujuće, dva spoja davana u dozama koje same nisu uopće bile učinkovite, kada su se davali istodobno doveli su do vrlo jakog bronhodilatornog učinka kod zamoraca, jasno pokazujući sinergističku prirodu ovog međusobnog djelovanja.
A sludge drying bed (14) comprising: 
Ležište za sušenje mulja (14), naznačeno time što sadrži:
an aluminium hydroxide and/or an aluminium phosphate). 
aluminijev hidroksid i/ili aluminijev fosfat).
Meter according to claims 12 or 13, wherein the communication module is arranged to transmit an alarm signal upon change in the electric signal from the detector coil (C) being detected. 
Mjerač prema zahtjevima 11 ili 12, gdje komunikacijski modul odašilje signal alarma nakon otkrivanja promjene električnog signala iz zavojnice detektora (C).
A compound of formula (I) as defined in any one of claims 1 to 10 or a physiologically acceptable solvate thereof for use in veterinary or human medicine. 
Spoj formule (I), ili njegov fiziološki prihvatljiv solvat, u skladu s patentnim zahtjevom 1 ili patentnim zahtjevom 2, naznačen time što je namijenjen upotrebi u veterini ili madicini.
Pharmaceutical compositions as claimed in claims 1-15, also containing sodium edetate as preservative and chelating agent. 
Farmaceutski pripravci kako su navedeni u patentnim zahtjevima 1-15, naznačeni time da sadrže natrijev edetat kao konzervans ili sredstvo za keliranje.
a central feed hopper (1) for delivering the articles to a shaker conveyor or a conveyor belt (2) supplying the auxiliary tube (7) via: 
središnjem spremniku za napajanje (1) za isporuku čestica u tresući transporter ili na transportnu traku (2) koji napaja pomoćnu cijev (7) preko:
In a further embodiment thirty nine the present invention provides an antibody or antigen-binding fragment or pharmaceutical composition according to any one of the embodiments 1-37, wherein the use is the treatment of an inflammatory disease, of an autoimmune disease, of a respiratory disease, of a metabolic disorder, of an epithelial mediated inflammatory disorder, fibrosis or of cancer. 
Protutijelo ili njegov fragment koji veže antigen ili farmaceutski pripravak za uporabu prema patentnom zahtjevu 6, naznačeni time, da se kod uporabe u medicini radi o uporabi u postupku liječenja upalne bolesti, autoimune bolesti, respiratorne bolesti, metaboličkog poremećaja, upalnog epitelno posredovanog poremećaja, fibroze ili raka.
For parenteral compositions, the carrier will usually comprise sterile water, at least in large part, though other ingredients, for example, to aid solubility, may be included. 
Kod parenteralnih pripravaka, nosač obično sadržava sterilnu vodu, barem u većem dijelu, iako mogu biti uključeni i drugi sastojci kako bi se na primjer potpomogla topljivost.
A plant cell having a cell wall and transfected with a nanoparticle coated with an SSN, wherein the nanoparticle is a dendrimeric nanomatrix or a nanoparticle that is coated with a cell-penetrating peptide. 
Bilja stanica koja ima stanični zid a tranfektirana je nanočesticom obloženom sa SSN, naznačeno time da je nanočestica dendrimerna nanomatrica ili nanočestica koja je obložena sa u stanicu penetrirajućim peptidom.
The method of claim 13, wherein the compound of formula (I) is administered together with a Bcl−XL inhibitor. 
Spoj sa formulom (I) za primjenu iz patentnog zahtjeva 11, gdje spoj sa formulom (I) je administrirano zajedno sa BCI-xr inhibitorom.
This precipitated material settled out and so did not cause turbidity, explaining the low t value in Figure 5. 
Ovaj istaloženi materijal se slegao i tako nije uzrokovao zamućenost, objašnjavajući nisku vrijednost T na Slici 5.
Buffer is oxygenated with 95% O2/5% CO2 for 10 min at 37° C. and pH is adjusted 7.4. 
Bufer se oksidira s 95% O2/5% CO, tijekom 10 minuta na 37 stupnjeva C i pH se adaptira s 7.4.
The transdermal dosage forms that can be used in accordance with the present invention may optionally include a permeation enhancing agent. 
Transdermalni oblici doziranja koji se mogu koristiti u skladu s ovim izumom mogu opcionalno uključivati sredstvo za poboljšavanje prodiranja.
Methanol (420 mL) was added slowly and stirred well. 
Polako se doda metanol (420 ml), te dobro promiješa.
is selected from the group consisting of 
se bira iz skupine koju čine
As used herein, the term "compactin batch" refers to a composition consisting essentially of compactin, which composition may contain low levels of impurities, one of which may be compactin C. As used herein relative to a compactin batch, the term "sample" refers to a portion of the "compactin batch" that is taken for the purpose of measuring the compactin C level. 
Kako je ovdje korišten, pojam "serija kompaktina" odnosi se na smjesu koja se u biti sastoji od kompaktina, a može sadržavati i male količine onečišćenja od kojih jedno može biti i kompaktin C. Kada se ovdje koristi u odnosu na seriju kompaktina, pojam "uzorak" se odnosi na dio "serije kompaktina" koji se uzima u svrhu mjerenja razine kompaktina C.
a T cell receptor a-chain comprising all three of the CDR sequences of the T cell receptor a-chain of SEQ ID NO: x, and a T cell receptor B-chain comprising all three of the CDR sequences of a T cell receptor B-chain of SEQ ID NO: x+1; wherein x selected from the group consisting of 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26 and 28 and 
(i) o-lanac T staničnog receptora koji sadrži sve tri CDR sekvence a-lanca T staničnog receptora od SEK ID BR: x,1 (ii) B-lanac T staničnog receptora koji sadrži sve tri CDR sekvence B-lanca T staničnog receptora od SEK IDBR:x +1; naznačen time, da je x odabran iz skupine sastavljene od 6, 8, 10, 12, 14, 16, 18, 20, 22,24, 26128 i
The aqueous pharmaceutical suspension according to claim 7, optionally further comprising, by weight/volume (g/100 mL), about 1.5% to about 2.0% of microcrystalline cellulose. 
Vodena farmaceutska suspenzija u skladu s patentnim zahtjevom 7, naznačena time što izborno dodatno sadrži, težinski/volumno (g/100 ml), otprilike 1,5 % do otprilike 2,0 % mikrokristalne celuloze.
or a pharmaceutically acceptable salt thereof, under suitable conditions to form the compound of formula (4), or a pharmaceutically acceptable salt thereof. The method of claim 1 further comprising resolving the compound of formula (I), or a pharmaceutically acceptable salt thereof, under suitable conditions, to yield a compound of formula (I-S): 
Postupak u skladu s patentnim zahjevom 7, naznačen time što se dodatno sastoji u razdvajanju spoja formule (D, ili njegove farmaceutski prihvatljive soli, u obliku smjese enantiomera, u uvjetima pogodnim za dobivanje spoja formule (I-$):
Some proteins have more than one Ig-like domain, for example the mature type II IL-1 receptor has three immunoglobulin-like domains (McMahan et al. 
Neki proteini posjeduju više od jedne Ig-slične domene, primjerice zreli receptor IL-1 tipa II posjeduje tri domene slične imunoglobulinskoj (McMahan i sur.
Preferably a fluidised bed coater is used, e.g. a bottom, a tangential or a top-spray coater. 
Po mogućnosti se upotrebljava uređaj za oblaganje u fluidiziranom sloju, primjerice uređaj za oblaganje uz prskanje odozdo, tangencijalno ili odozgo.
b') reaction of the diamine (11) with Boc-D-Phe to give the intermediate (12) or alternatively through the following steps: 
"OLI (3 N b') reakcija diamina (11) s Boc-D-Phe kojom nastaje međuprodukt (12) ili alternativno preko sljedećih koraka: a") reakcija 4-aminometil-piperidina (2)
For example compound of formula (V), when m and o represent 2, p represents 2 and q represents 0, may be prepared according to the method defined in scheme 3 and starting from compound (VI), wherein R4 is as defined for formula (I) The conditions which may be used are given in the chemical examples. 
Kao primjer, spoj formule (V), kada m i o predstavljaju 2, p znači 2, a q znači 0, može se dobiti postupkom definiranim u Shemi 3, počevši od spoja (VI), gdje R4 je definiran kao za formulu (1). Radni uvjeti dani su u kemijskim primjerima.
reacting piperidine-3-carbonyl azide in the presence of water and an acid, at a temperature in the range of 50 to 150° C., whereby piperidine-3-carbonyl azide is converted into 3-aminopiperidine, where steps b) and c) are performed without isolation of piperidine-3-carbonyl azide, and 
reakciju piperidin-3-karbonil-azida u prisutnosti vode i kiseline, pri čemu se piperidin-3-karbonil-azid pretvara u 3-aminopiperidin, gdje se koraci b) i c) provode bez izolacije piperidin-3-karbonil-azida.
The composition of claim 3, wherein said composition comprises a pH-sensitive coating. 
Sastav u skladu s patentnim zahtjevom 3, pri čemu navedeni sastav uključuje pH-osjetljivi omotač.
The compound of claim 5, wherein R8 is a -CF3 group or R8 is a -(C1-C6)alkyl group, preferably a tert -butyl group or an iso -propyl group. 
Spoj prema zahtjevu 5, naznačen time da Rz je a -CF; skupina ili Rz je a Â«(C,-Cg)alkil skupina, poželjno tert-butil skupina ili izo-propil skupina.
The internal means 11 of the seat may for example comprise threads, whereby the expansion means 10 and the suspension element 16, respectively, may be screwed on to the rock bolt 7 . 
Unutarnje sredstvo 11 sjedišta može na primjer imati narez, pomoću kojeg se ekspanziono sredstvo 10, odnosno ovjesni element 16 mogu navrnuti na sidro u stijeni 7.
A pharmaceutical composition comprising said compound or salt of claim 13 in combination with a pharmaceutically acceptable carrier or excipient. 
Farmaceutski pripravak, naznačen time, da sadrži navedeni spoj ili sol prema zahtjevu farmaceutski prihvatljivim nosačem ili pomoćnom tvari. prihvatljiv nosač ili pomoćnu tvar.
The method of paragraph 3, wherein, the baseline telomere length is determined by FISH analysis, 
Postupak prema zahtjevu 1, pri čemu je osnovna duljina telomere određena pomoću FISH analize.
Patients with recurrent candidiasis often resort to home remedies, such as vaginal yoghurt douches or special diets, and some women derive some benefit from them. 
Pacijenti s recesivnom kandidijazom često se utječu domaćim lijekovima, kao što su vaginalna ispiranja jogurtom ili specijalna prehrana, a neke žene imaju i koristi od toga.
The compound of claim 1, wherein the compound is selected from the group consisting of 
Spoj prema zahtjevu 1, naznačen time da je spoj odabran iz skupine koju čine:
fed under pressure to a second filter 14c of the third station 15c, with minimum passage aperture of 40 micron; then granulated. 
- < dopremi se pod tlakom do drugog filtra 14c treće stanice 15c, s minimalnim otvorom prolaza od 40 mikrona; tada se granulira.
98-100% of the seeds demucilaged according to Examples 1-3 sprout proving the fact that the demucilaged flax seed are viable. 
Postupak prema zahtjevu 3, naznačen time što se nakon enzimske obrade, sjemenke namaču do zasićenja vodom.
inserting a section of a person's natural hair and a single narrowed tip section formed from hair strands of a hair extension into a deformable member; wherein the hair extension comprises: 
umetanje dijela prirodne kose i dijela vrha (120) ekstenzije za kosu (100) kako je definirano u zahtjevima 1 ili 2, u deformabilni član (200); i
The medication delivery device according to claim 1, wherein the adjusted medication dose AD is equal to the first dose if the variable B is negative and is equal to the second dose if the variable B is positive. 
Uređaj za izdavanje lijeka u skladu sa zahtjevom 1 naznačen time da je prilagođena doza lijekova AD jednaka prvoj dozi ako je varijabla B negativna i jednaka drugoj dozi ako je varijabla B pozitivna.
The disadvantage of this method is that it does not provide for the effects on oil during its transport by oil-well tubing, thus decreasing the efficiency of the method. 
Nedostatak je ove metode to što ne utječe na naftu za vrijeme njenog prijenosa cjevovodima naftnog izvora, što smanjuje učinkovitost metode.
A mucosal bioadhesive slow release carrier obtainable by the method of claim 1, comprising 10 to 200 mg of an antiviral agent selected from the group of acyclovir, valacyclovir, gancyclovir and zidovudine, 1 to 75 % by weight of microcrystalline cellulose, 2 to 10 % by weight of sodium lauryl sulphate and 0.5to 5 % by weight of polyvinylpyrrolidone and 10 to 40 % by weight of at least one bioadhesive polymer selected from the group of natural milk proteins and mixtures thereof and 10% to 40% by weight of hypromellose. 
Nosač bioadhezivan za sluznicu sa sporim oslobađanjem koji se može dobiti pomoću postupka prema patentnom zahtjevu 1, naznačen time što sadrži 10 do 200 mg antivirusnog sredstva koji je izabran iz grupe koju čine aciklovir, valaciklovir, ganciklovir i zidovudin, 1 do 75 težinskih % mikrokristalne celuloze, 2 do 10 težinskih % natrij lauril sulfata i 0.5 do 5 težinskih % polivinilpirolidona i 10 do 40 težinskih % najmanje jednog bioadhezivnog polimera koji je izabran iz grupe koju čine prirodni proteini mlijeka i njihove smjese i 10% do 40 težinskih % hipromeloze.
A method for treating or preventing endothelial dysfunction, comprising administering an effective amount of the peptide or a pharmaceutically acceptable salt of the peptide of any one of embodiments 1 to 75 to a mammal in need thereof. 
Peptid ili farmaceutski prihvatljiva sol navedenog peptida prema bilo kojem od zahtjeva 1 do 13, ili pripravak prema zahtjevu 14, naznačen time da je za uporabu za liječenje ili spriječavanje dislipidemije, kardiovaskularne bolesti, endotelijalne disfunkcije, makrovaskularnog poremećaja i/ili mikrovaskularnog poremećaja kod sisavca.
Spraying speed of the pelletizing liquid was set at 50 ml/min, pressure of spraying air was 2.5 bar. 
Brzina raspršivanja tekućine za granuliranje postavljena je na 50 ml/min, a tlak raspršivanja bio je 2,5 bar.
purifying a micelle particle comprising the RV G protein trimers in the presence of NP-9 detergent. 
Pročišćavanje G proteina od virusa bjesnila (RV) u obliku micela.
A neutralising antibody which binds human IL-17A and human IL-17F, comprising a heavy chain and a light chain wherein the heavy chain variable domain comprises the sequence given in SEQ ID NO:9 and the light chain variable domain comprises the sequence given in SEQ ID NO:7 or a sequence at least 95% identical thereto and wherein the antibody has an affinity for IL-17A of better than 20pM and an affinity for IL-17F of better than 2nM. 
Neutralizirajuće protutijelo koje se veže za humani IL-17A i humani IL-17F naznačeno time da ima afinitet vezanja za IL-17 bolje nego 2 nM i afinitet vezanja za IL-17A bolje nego 100 pM kako je izmjereno sa površinskom rezonancom plazmona. Neutralizirajuće protutijelo prema zahtjevu 1, naznačeno time da se veže za humani IL-17A i humani i IL-17F koji sadrži teški lanac, pri čemu varijabilno područje jakog lanca sadrži sekvencu danu u SEQ ID NO:1 za CDR-H1, sekvencu danu u SEQ ID NO:2 za CDR-H2 i sekvencu danu u SEQ ID NO:3 za CDR-H3.
The method of claim 9, wherein the therapeutically effective amount is administered to the subject for at least 12 weeks. A method of treating a subject in need of treatment for multiple sclerosis consisting essentially of orally administering to the subject about 480 mg per day of dimethyl fumarate, monomethyl fumarate, or a combination thereof. 
Dimetil fumarat ili monometil fumarat za upotrebu u liječenju multiple skleroze, naznačen time da je dimetil fumarat ili monometil fumarat jedini neuroprotektivni spoj koji se primjenjuje, i pri čemu se dimetil fumarat ili monometil fumarat oralnim putem daje osobi kojoj je potrebno liječenje multiple skleroze u dozi od 480 mg dnevno.
an amino acid sequence which is a fragment which has a stretch of amino acids comprising amino acid residues from 1 to 860 or from 2 to 860 of SEQ ID NO:1, into which: 
(a) aminokiselinska sekvenca koja je fragment čiji se lanac aminokiselina proteže u sastavu aminokiselinskih ostataka od 1 do 860 ili od 2 do 860 iz SEQ ID NO:1, gdje:
Soft meringue made with the sugar replacement composition according to the invention has the same structural stability as soft meringue made with sugar, but the brilliance is higher. 
Meka beze-smjesa (tučeni bjelanjak sa šećerom), pripravljena sa sastavinom iz ovog izuma koja zamjenjuje šećer, ima jednaku strukturnu stabilnost kao i smjesa pripravljena sa šećerom, no ima viši sjaj.
The compound of Claim 4, which is selected from the group consisting of compounds with the formula (a) to (c), or a pharmaceutically acceptable salt thereof: 
Spoj prema patentnom zahtjevu 1, naznačen time što je izabran iz grupe koju čine spojevi sa formulom (a) do (c), ili njegova farmaceutski prihvatljiva sol:
The compound or a pharmaceutically acceptable acid addition salt thereof according to claim 3, wherein R1 is a hydrogen atom, a fluorine atom, a chlorine atom, a methyl group, a fluoromethyl group, a difluoromethyl group, a trifluoromethyl group, an ethyl group, a 1,1-difluoroethyl group, a methoxy group, a fluoromethoxy group, a difluoromethoxy group, a trifluoromethoxy group, an ethoxy group, a 2-fluoroethoxy group, a 2-propyloxy group, a cyclopropylmethoxy group, a cyclopropyloxy group or an (oxetan-3-yl)oxy group. 
Spoj ili njegova farmaceutski prihvatljiva kisela adicijska sol prema zahtjevu 3, pri čemu R, je vodikov atom, fluorov atom, klorov atom, metilna skupina, fluorometilna skupina, difluorometilna skupina, trifluorometilna skupina, etilna skupina, 1,1-difluoroetilna skupina, metoksi skupina, fluorometoksi skupina, difluorometoksi skupina, trifluorometoksi skupina, etoksi skupina, 2-fluoroetoksi skupina, 2-propiloksi skupina, ciklopropilmetoksi skupina, ciklopropiloksi skupina ili (oksetan-3-il)oksi skupina.
The solvent was removed under reduced pressure and the solids were re-suspended in ethyl acetate (100 mL) and NaHCO3 (sat.) 
Otapalo se ukloni pri sniženom tlaku HR P20070194 T3 i krutine se resuspendiraju u etil acetatu (100 ml) i NaHCO; (zas.)
The cosmetic method of claim 28, where the ageing of the skin is caused by the exposure of the skin to the sun's rays. 
Pripravak namijenjen upotrebi u skladu s patentnim zahtjevom 8, naznačen time što je stanično starenje posljedica izlaganja kože suncu.
wherein at least one of the intersubunit linkages is linkage (B), or wherein each linkage (B) if present has the same structure at each occurrence; and wherein the antisense oligonucleotide is covalently attached to a cell-penetrating peptide and linker moiety, wherein the linker moiety is selected from glycine, cysteine, proline, 6-aminohexanoic acid (Ahx), B-alanine (B), and Ahx-B, and the cell-penetrating peptide is selected from SEQ ID NOs: 39-54. 
pri čemu barem jedna od veza između podjedinica je veza (B), ili pri čemu svaka veza (B) ako postoji ima istu strukturu pri svakom pojavljivanju; i pri čemu je protusmjerni oligonukleotid kovalentno vezan na peptid koji prodire u stanicu i skupinu poveznice, pri čemu je skupina poveznice odabrana iz skupa koji čine glicin, cistein, prolin, 6-aminoheksanoična kiselina (Ahx), B-alanin (B), i Ahx-B, a peptid koji prodire u stanicu je odabran od SEQ ID NOs: 39-54.
Then the circulation loop flow is maintained at the final value for a duration within a range of about 20 minutes to about 40 minutes. 
Tada se cirkulacijski protok održava na konačnoj vrijednosti tijekom vremenskog razdoblja od oko 20 min pa do 40 min.
vegetable oils such as coconut oil, corn oil, cottonseed oil, olive oil, palm oil, peanut oil, rapeseed oil, canola oil, safflower oil, sesame oil, soybean oil, sunflower oil, almond oil, beech nut oil, cashew oil, hazelnut oil, macadamia oil, pine nut oil, pistachio oil, walnut oil, citrus oils, grapefruit seed oil, lemon oil, orange oil, castor oil, hemp oil, mustard oil, radish oil, rice bran oil, salicornia oil, jatropha oil, jojoba oil, linseed oil, poppy oil, stillingia oil, fruit tree oil, artichoke oil, carrot seed oil, mango oil and sea-buckthorn oil; 
- biljna ulja kao što je kokosovo ulje, kukuruzno ulje, ulje sjemenki pamuka, maslinovo ulje, palmino ulje, ulje kikirikija, ulje sjemenki uljane repice, ulje uljane repice, ulje šafranike, ulje sezama, sojino ulje, suncokretovo ulje, bademovo ulje, ulje sjemenki bukve, ulje Anacardium occidentale, ulje lješnjaka, ulje makadamije, ulje pinjola, ulje pistacija, ulje orata, ulja citrusa, ulje sjemenki grejpa, ulje limuna, ulje naranče, ricinusovo ulje, ulje konoplje, ulje gorušice, uije rotkvice, ulje zrna riže, ulje caklenjače, ulje jatrofine, ulje jojobe, ulje sjemenki lana, ulje maka, ulje Sapium sebirefum, ulje voćke, ulje artičake, ulje sjemenki mrkve, ulje manga te ulje morske pasjakovine;
Alkynyl (K) is converted to an alkynyl ester of Formula (L, wherein R15 is C1-8 alkyl) by treatment with a strong base followed by reacting with a C1-8 alkyl chlorofommate. A suitable strong base is an alkyl lithium, for example but not limited to, n-butyl lithium, t-butyl lithium and the like. 
Alkinil (K) se prevodi u alkinil ester Formule (L, gdje je R15 C,.g alkil) tretiranjem s jakom bazom nakon čega slijedi reakcija sa C;.g alkil kloroformatom, Prikladna jaka baza je alkil litij, na primjer ali bez ograničavanja, n-butil litij, t-butil litij i slično.
the motor (17) is activated, rotating the inner rotor (IR) to a desired rotation angular frequency (w) while the outer shell(OS) is kept within the same cold environment until the temperature stabilizes under rotation conditions; 
- < motor (17) se aktivira, izazivajući rotaciju unutarnjeg rotora (UR) i njegovo ubrzavanje do željene ugaone brzine (10), dok se vanjsko kućište (SK) 1 dalje drži u hladnoj ambijentalnoj sredini, sve dok se temperatura u sistemu ne stabilizira pri novoostvarenim uvjetima obrtanja rotora;
The recombinant human LAL for use according to claim 1, wherein said liver transaminase is selected from the group consisting of a serum aspartate transaminase (AST) and an alanine transaminase (ALT). 
Rekombinantna humana LAL za uporabu prema zahtjevu 1, naznačena time, da je navedena jetrena transaminaza odabrana iz skupine koju čine aspartatna transaminaza seruma (AST) i alaninska transaminaza (ALT).
is selected from the group consisting of H, alkyl and CH2CO2H. 
R? je odabran iz skupine koju čine H, alkil i RY;
The soft chewable veterinary composition of claim 1, wherein the isoxazoline of formula (I) is compound A: 
Mekani veterinarski pripravak za žvakanje u skladu sa zahtjevom 1, naznačen time, da izoksazolin formule (I) je spoj A (engl. compound A):
From the above explanations and Figures 3 and 4 it is clear that the electrical motor 12 can be dimensioned relatively small as its torque is transmitted by mechanical transmission means (lever arrangement 19) into a closure force which is increasing with the course of the closure transfer movement. 
Iz gornjeg objašnjenja 1 iz slika 3 i 4 je jasno da elektromotor 12 može biti dimenzioniran tako da je relativno malen, budući da se njegov okretni moment prenosi pomoću sredstva za mehanički prijenos (naprava s polugama 19) u zatvoren sustav sila koji se povećava tijekom kretanja pri premještanju položaja.
The method may further comprise applying a third layer, which may be an outer layer, of polymeric material over the second layer, which may be non-foamed, the polymeric material in the third layer being foamed. 
Postupak sukladno patentnom zahtjevu 3 ili patentnom zahtjevu 4 nadalje obuhvaća nanošenje trećeg sloja polimernog materijala preko drugog sloja, polimerni materijal u trećem je sloju pjenast.
The layer sequence repeater module of claim 1, further comprising one or more cells of axially disposed annular disks. 
Modul za ponavljanje niza slojeva u skladu s patentnim zahtjevom 1, naznačen time što dodatno sadrži jednu ili više ćelija (30) aksijalno smještenih prstenastih diskova.